[Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (part 2)]

S Nguyen1, D Blaise2, J-O Bay3

  • 1Service d'hématologie, G.H. Pitié-Salpêtrière, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France.

Pathologie-Biologie
|June 24, 2014
PubMed

Insights

Haploidentical allogeneic stem cell transplantation is a growing alternative to other stem cell sources. Further research is needed to confirm its role in routine patient care, with ongoing efforts to standardize practices.

Area of Science:

  • Hematology
  • Transplantation immunology
  • Cell therapy

Context:

  • Haploidentical allogeneic stem cell transplantation (CST) has gained significant traction globally over the last ten years.
  • It presents a viable alternative to conventional stem cell sources.
  • Standardization of clinical practices across different French transplantation centers is an ongoing objective.

Purpose:

  • To harmonize clinical practices for haploidentical allogeneic stem cell transplantation (CST) among French centers.
  • To present part two of the recommendations for allogeneic stem cell transplantation from an HLA-haploidentical related donor.
  • To facilitate discussion and consensus among practitioners at the SFGM-TC workshops.

Summary:

  • The French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC) convened its fourth annual workshop in Lille, September 2013.
  • Practitioners from SFGM-TC member centers collaborated to discuss and refine recommendations for CST.
  • This part two focuses specifically on allogeneic transplantation using HLA-haploidentical related donors.

Impact:

  • Aims to establish standardized protocols for haploidentical CST, potentially improving patient outcomes.
  • Contributes to the validation of CST as a standard care option.
  • Fosters collaboration and knowledge exchange within the French transplantation community.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.8K